Literature DB >> 20211986

FXR regulates liver repair after CCl4-induced toxic injury.

Zhipeng Meng1, Yandong Wang, Lin Wang, Wen Jin, Nian Liu, Hao Pan, Lucy Liu, Lawrence Wagman, Barry M Forman, Wendong Huang.   

Abstract

Liver repair is key to resuming homeostasis and preventing fibrogenesis as well as other liver diseases. Farnesoid X receptor (FXR, NR1H4) is an emerging liver metabolic regulator and cell protector. Here we show that FXR is essential to promote liver repair after carbon tetrachloride (CCl(4))-induced injury. Expression of hepatic FXR in wild-type mice was strongly suppressed by CCl(4) treatment, and bile acid homeostasis was disrupted. Liver injury was induced in both wild-type and FXR(-/-) mice by CCl(4), but FXR(-/-) mice had more severe defects in liver repair than wild-type mice. FXR(-/-) livers had a decreased peak of regenerative DNA synthesis and reduced induction of genes involved in liver regeneration. Moreover, FXR(-/-) mice displayed increased mortality and enhanced hepatocyte deaths. During the early stages of liver repair after CCl(4) treatment, we observed overproduction of TNFalpha and a strong decrease of phosphorylation and DNA-binding activity of signal transducer and activator of transcription 3 in livers from FXR(-/-) mice. Exogenous expression of a constitutively active signal transducer and activator of transcription 3 protein in FXR(-/-) liver effectively reduced hepatocyte death and liver injury after CCl(4) treatment. These results suggest that FXR is required to regulate normal liver repair by promoting regeneration and preventing cell death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211986      PMCID: PMC3284774          DOI: 10.1210/me.2009-0286

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  45 in total

Review 1.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 2.  FXR, a target for different diseases.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Wendong Huang
Journal:  Histol Histopathol       Date:  2008-05       Impact factor: 2.303

3.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

Authors:  F Liu; Y Song; D Liu
Journal:  Gene Ther       Date:  1999-07       Impact factor: 5.250

Review 4.  Cytokines, STATs and liver disease.

Authors:  Bin Gao
Journal:  Cell Mol Immunol       Date:  2005-04       Impact factor: 11.530

Review 5.  Mechanism of impaired hepatic regeneration in cholestatic liver.

Authors:  Yukihiro Yokoyama; Masato Nagino; Yuji Nimura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-03-27

6.  The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.

Authors:  Stefano Fiorucci; Elisabetta Antonelli; Giovanni Rizzo; Barbara Renga; Andrea Mencarelli; Luisa Riccardi; Stefano Orlandi; Roberto Pellicciari; Antonio Morelli
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.

Authors:  Wendong Huang; Ke Ma; Jun Zhang; Mohammed Qatanani; James Cuvillier; Jun Liu; Bingning Dong; Xiongfei Huang; David D Moore
Journal:  Science       Date:  2006-04-14       Impact factor: 47.728

8.  Pregnane X receptor is essential for normal progression of liver regeneration.

Authors:  Guoli Dai; Lin He; Pengli Bu; Yu-Jui Yvonne Wan
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

9.  FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.

Authors:  Qiuhong Zhang; Fengtian He; Ramalinga Kuruba; Xiang Gao; Annette Wilson; Jiang Li; Timothy R Billiar; Bruce R Pitt; Wen Xie; Song Li
Journal:  Cardiovasc Res       Date:  2007-11-13       Impact factor: 10.787

10.  Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.

Authors:  Kimberly J Riehle; Jean S Campbell; Ryan S McMahan; Melissa M Johnson; Richard P Beyer; Theo K Bammler; Nelson Fausto
Journal:  J Exp Med       Date:  2007-12-24       Impact factor: 14.307

View more
  42 in total

1.  Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1.

Authors:  Chan Gyu Lee; Young Woo Kim; Eun Hyun Kim; Zhipeng Meng; Wendong Huang; Se Jin Hwang; Sang Geon Kim
Journal:  Gastroenterology       Date:  2012-01-18       Impact factor: 22.682

2.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

3.  FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.

Authors:  Min Zhang; Bo Kong; Mingxing Huang; Ruixuan Wan; Laura E Armstrong; Justin D Schumacher; Daniel Rizzolo; Monica D Chow; Yi-Horng Lee; Grace L Guo
Journal:  Dig Liver Dis       Date:  2018-04-23       Impact factor: 4.088

4.  miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice.

Authors:  Zhipeng Meng; Xianghui Fu; Xiaosong Chen; Samuel Zeng; Yan Tian; Richard Jove; Rongzhen Xu; Wendong Huang
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

Review 5.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

6.  Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.

Authors:  Shogo Takahashi; Naoki Tanaka; Srujana Golla; Tatsuki Fukami; Kristopher W Krausz; Marianne A Polunas; Blair C Weig; Yusuke Masuo; Cen Xie; Changtao Jiang; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2017-08-01       Impact factor: 4.849

7.  Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression.

Authors:  Nian Liu; Zhipeng Meng; Guiyu Lou; Weiping Zhou; Xiaoqiong Wang; Yunfeng Zhang; Lisheng Zhang; Xiyong Liu; Yun Yen; Lily Lai; Barry M Forman; Zhonggao Xu; Rongzhen Xu; Wendong Huang
Journal:  Mol Endocrinol       Date:  2012-04-02

8.  Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.

Authors:  Prachi Borude; Genea Edwards; Chad Walesky; Feng Li; Xiaochao Ma; Bo Kong; Grace L Guo; Udayan Apte
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

9.  Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor α.

Authors:  Cheng Wang; Fengxiao Zhang; Lin Wang; Yanqing Zhang; Xiangrao Li; Kun Huang; Meng Du; Fangmei Liu; Shizheng Huang; Youfei Guan; Dan Huang; Kai Huang
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

10.  Bile Acid Receptors and Liver Cancer.

Authors:  Xichun Wang; Xianghui Fu; Carl Van Ness; Zhipeng Meng; Xiaoxiao Ma; Wendong Huang
Journal:  Curr Pathobiol Rep       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.